Regulations

Fight against pharma counterfeiting must go deeper: TruTag

13-Jan-2021 By Jenni Spinner

A leader from the anti-counterfeit solutions firm says that while packaging-level efforts may have an effect, on-dose technology is worth a closer look.

Global alliance unites pharma pros to battle counterfeiting

13-Jan-2021 By Jenni Spinner

Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.

FDA COVID-19 weekly action and advice update

13-Jan-2021 By Jenni Spinner

Industry professionals and consumers alike continue to look to the US agency for action, advice and news related to the global COVID-19 response.

First FDA COVID-19 update of 2021

04-Jan-2021 By Jenni Spinner

As healthcare providers and other high-priority patients begin receiving the vaccines, the agency continues to act to help the national pandemic response.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

Researchers ‘must embrace the change’ in the year ahead: PRA

16-Dec-2020 By Jenni Spinner

The head of the CRO’s Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.

New EU pharma strategy looks to future-proof healthcare sector, stimulate innovation and boost access to biosimilars and generics

25-Nov-2020 By Jane Byrne

The new EU Pharmaceutical Strategy, adopted today by the European Commission, is designed to improve and accelerate patients’ access to safe and affordable medicines and address unmet medical needs in the areas of antimicrobial resistance, cancer, and...

Advarra acquires Longboat

25-Nov-2020 By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

FDA grants EUA for combo COVID-19 treatment

23-Nov-2020 By Jenni Spinner

The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.

FDA COVID-19 news roundup this week

18-Nov-2020 By Jenni Spinner

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

Digital trial evolution takes center stage in online event

17-Nov-2020 By Jenni Spinner

During a free editorial webinar on December 9, a panel of clinical trial experts will offer a range of insights into the future of research technology.

Latest FDA updates on COVID-19 battle

12-Nov-2020 By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

FDA okays first COVID-19 treatment

26-Oct-2020 By Jenni Spinner

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

WuXi AppTec: think ahead when dual-filing IND applications

20-Oct-2020 By Jenni Spinner

A leader from the company advises planning ahead when filing investigational new drug applications to avoid wasting time, work and money later.

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

19-Oct-2020 By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.